Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma

被引：1
|
作者：
Vonasek, Julia [1 ]
Edslev, Pernille Wendtland [1 ]
d'Amore, Francesco [2 ]
Hasle, Henrik [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Pediat & Adolescent Hlth, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 02期
关键词：
D O I：
10.1002/pbc.28082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Brentuximab vedotin for the treatment of Hodgkin's and non-Hodgkin's lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 609 - 618
  • [32] A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin
    Cao, Zhi-Gang
    Zhou, Hong-Wei
    Peng, Chao-Jin
    Liu, Mo
    Du, Yu
    Yang, Qing-Ming
    CHINESE JOURNAL OF CANCER, 2013, 32 (09) : 520 - 523
  • [33] Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin
    Wagner-Johnston, Nina D.
    Bartlett, Nancy L.
    Cashen, Amanda
    Berger, Joseph R.
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2283 - 2286
  • [34] A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD
    Sorella, S.
    Assanto, G. M.
    D'Elia, Gianna Maria
    Annechini, Giorgia
    Totaro, Matteo
    Celia, Renata
    Bruno, Leonardo
    Placidi, Fabio
    Martelli, M.
    Del Giudice, I.
    LEUKEMIA & LYMPHOMA, 2024, 65 (12) : 1913 - 1916
  • [35] A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin
    Zhi-Gang Cao
    Hong-Wei Zhou
    Chao-Jin Peng
    Mo Liu
    Yu Du
    Qing-Ming Yang
    Chinese Journal of Cancer, 2013, 32 (09) : 520 - 523
  • [36] Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without Transfusion
    Marin, Ellen
    Abousaud, Aseala
    Davis, Kathleen
    Sumrall, Bradley
    Li, Shiyong
    Langston, Amelia A.
    Chang, Andres
    EJHAEM, 2025, 6 (01):
  • [37] Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
    Forlenza, Christopher J.
    Gulati, Nitya
    Mauguen, Audrey
    Absalon, Michael J.
    Castellino, Sharon M.
    Franklin, Anna
    Keller, Frank G.
    Shukla, Neerav
    BLOOD ADVANCES, 2021, 5 (24) : 5519 - 5524
  • [38] Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
    Castellino, Sharon M. M.
    Pei, Qinglin
    Parsons, Susan K. K.
    Hodgson, David
    McCarten, Kathleen
    Horton, Terzah
    Cho, Steve
    Wu, Yue
    Punnett, Angela
    Dave, Hema
    Henderson, Tara O. O.
    Hoppe, Bradford S. S.
    Charpentier, Anne-Marie
    Keller, Frank G. G.
    Kelly, Kara M. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1649 - 1660
  • [39] Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphoma
    Nikolaenko, Liana
    Nademanee, Auayporn
    FUTURE ONCOLOGY, 2020, 16 (29) : 2273 - 2282
  • [40] Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma
    Vitolo, Umberto
    Chiappella, Annalisa
    LANCET ONCOLOGY, 2018, 19 (09): : 1144 - 1146
12345